Skip to main content
Premium Trial:

Request an Annual Quote

Judith Bandy, John Burke, William Hayes, Jack Leunissen, Mahendra Navarange, Kevin Prime, Martin Widlake, Charlie Berger, Raf Podowski, Mary Arbelaez

Premium

The Oracle Life Sciences User Group has elected its first board of directors. Members include: Judith Bandy, vice president of marketing, InforSense; John Burke, research software administrator, UCB Group; Mark Forster, chemical informatics systems team leader, Syngenta; William Hayes, associate director of research informatics, Biogen Idec; Jack Leunissen, professor of bioinformatics, Wageningen University; Mahendra Navarange, executive consultant, Atos Origin; Kevin Prime, director of quality assurance, Elsevier MDL; Martin Widlake, database services manager, Wellcome Trust Sanger Institute; Charlie Berger, senior director of product management, life sciences and data mining technologies, Oracle; Raf Podowski, senior product manager, life sciences, Oracle; and Mary Arbelaez, director of business development, Oracle.

Filed under

The Scan

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.

Fragile X Syndrome Mutations Found With Comprehensive Testing Method

Researchers in Clinical Chemistry found fragile X syndrome expansions and other FMR1 mutations with ties to the intellectual disability condition using a long-range PCR and long-read sequencing approach.

Team Presents Strategy for Speedy Species Detection in Metagenomic Sequence Data

A computational approach presented in PLOS Computational Biology produced fewer false-positive species identifications in simulated and authentic metagenomic sequences.

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.